Ethema Health Corp (GRST)

[Bubae]

No one can tell you when they will split the stock so stop wit the BS. I have been talking about the potential for reverse split since they dumped right at 1 billion new shares is Q3 and Q4 2021 taking this into the trips for the start of 2022. Maybe if Shan Leon had done what he should have done he wouldn't have had the debt go into default. Maybe he wouldn't have needed to hand over their best performing wholly owned asset in the Canadian property to Leonite. Maybe the could have purchased the treatment center property like they said instead of the crazy property purchase, sale, lease back deal to refinance the mess into a long term liability that now must be paid on monthly, On and On...

Now they continue to borrow because apparently Shawn still hasn't come up with a scheme to get that regulation "A" offering sold. Once he does however you can bet there will be a split. Shawn Leon moves at a glacial pace and by the time he does act the benefit is largely lost. That will be the case for this regulation "A" offering as well in my opinion. By the time he makes it viable it will do little other than retire some debt instead of something constructive for shareholder value.

Going back to December 2021 I find a post where I mentioned a reverse split. That post shows yet another example of how dishonest the people behind this are. The FAQ page release July 27th and a response to the question of dilution. They state that the end is coming soon and that it has been on the decline in the previous three months. But that wasn't the case was it, in fact they went on to dump right at 1 billion new shares in Q3 and Q4 2021 after saying that it would end soon.



Bubae
Member Level
Re: StockLogistics post# 40286
Friday, December 24, 2021 4:20:21 PM
Post# 40293 of 49755
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167252620

The company really should answer some questions about previous comments. One about the reverse split issue in light of the recent share structure destruction and the debt amount of debt that is currently eligible.

Another would be about the about the statement that the dilution would stop soon in the July 2021 document. I bet a lot of traders have banked losses based on that statement believing that they might catch a bottom.

Maybe the comment was based on the assumption in the quote. But to your point, they continue to borrow funds to operate because net earning even with the addition of ARIA isn't cutting it.

FAQ page release July 27, 2021
https://ethema.wpengine.com/?page_id=683

When will the debt be brought under control and when will the dilution stop?

"We cannot tell yet how much more conversion there will be but the rate and amount are in a dramatic decline. We do see an end coming soon since that has been the direction for much of the past three months."



For the quarterly period ended March 31, 2021
https://sec.report/Document/0001721868-21-000319/
Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share.The company has issued and outstanding 2,262,849,130 and 2,027,085,665 shares of common stock at March 31, 2021 and December 31, 2020, respectively

235,763,465 new shares for Q1 2021

For the quarterly period ended June 30, 2021
https://sec.report/Document/0001721868-21-000524/
Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 2,601,515,456 and 2,027,085,665 shares of common stock at June 30, 2021 and December 31, 2020, respectively. 338,666,326 shares for Q2

338, 666,326 increase for period Q2 2021


For the quarterly period ended September 30, 2021
https://sec.report/Document/0001721868-21-000835/
Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,111,047,811 and 2,027,085,665 shares of common stock at September 30, 2021 and December 31, 2020, respectively.

509,532,355 new shares for Q3 2021
For the fiscal year ended: December 31, 2021
https://sec.report/Document/0001903596-22-000192/

a) Common shares
Authorized and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,579,053,805 and 2,027,085,665 shares of common stock at December 31, 2021 and December 31, 2020, respectively.

468,005,994 new shares for Q4 2021